Identification of CD146 as a novel molecular actor involved in systemic sclerosis

0 avis

Identification of CD146 as a novel molecular actor involved in systemic sclerosis

Archive ouverte

Edité par CCSD ; Elsevier -

International audience. We highlight for the first time that CD146/sCD146 is involved in fibrotic process during SSc. sCD146 could thus constitute a new biomarker to assess disease activity, and potentially a new target for therapeutic applications.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

CD146 at the Interface between Oxidative Stress and the Wnt Signaling Pathway in Systemic Sclerosis

Archive ouverte | Heim, Xavier | CCSD

International audience. CD146 involvement was recently described in skin fibrosis of systemic sclerosis through its regulation of the Wnt pathway. Because the interaction between Wnt and ROS signaling plays a major ...

A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule

Archive ouverte | Nollet, Marie | CCSD

International audience. CD146 is an adhesion molecule present on many tumors (melanoma, kidney, pancreas, breast, ...). In addition, it has been shown to be expressed on vascular endothelial and smooth muscle cells....

Stem cell properties of peripheral blood endothelial progenitors are stimulated by soluble CD146 via miR-21: potential use in autologous cell therapy

Archive ouverte | Essaadi, Amel | CCSD

International audience. Cell-based therapies constitute a real hope for the treatment of ischaemic diseases. One of the sources of endothelial progenitors for autologous cell therapy is Endothelial Colony Forming Ce...

Chargement des enrichissements...